9.13
Certara Inc stock is traded at $9.13, with a volume of 4.44M.
It is up +5.67% in the last 24 hours and up +19.66% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$8.64
Open:
$8.85
24h Volume:
4.44M
Relative Volume:
1.40
Market Cap:
$1.39B
Revenue:
$419.75M
Net Income/Loss:
$-15.10M
P/E Ratio:
-95.80
EPS:
-0.0953
Net Cash Flow:
$63.10M
1W Performance:
-2.46%
1M Performance:
+19.66%
6M Performance:
+68.76%
1Y Performance:
-29.44%
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CERT
Certara Inc
|
9.13 | 1.39B | 419.75M | -15.10M | 63.10M | -0.0953 |
|
VEEV
Veeva Systems Inc
|
296.13 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.93 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
63.74 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
80.65 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HNGE
Hinge Health Inc
|
102.90 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara, Inc. (CERT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Certara, Inc. (CERT) Stock Forecasts - Yahoo Finance
Certara Launches Marvin Cloud Worldwide, Bringing Professional Chemical Structure Drawing to Independent Scientists and Students - BioBuzz
CERT Downgraded by UBS -- Rating Changed to Neutral - GuruFocus
Certara, Inc. (CERT) stock price, news, quote and history - uk.finance.yahoo.com
UBS Downgrades Certara to Neutral From Buy, $10 Price Target - Moomoo
UBS resumes Certara stock coverage with neutral rating, $10 target By Investing.com - Investing.com Nigeria
Certara, Inc. (CERT) Stock forecasts - uk.finance.yahoo.com
How Certara Inc. (CERT) Affects Rotational Strategy Timing - Stock Traders Daily
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Certara stock holds steady after recent earnings update - AD HOC NEWS
Certara stock edges lower as market watches valuation and analyst views - AD HOC NEWS
CERT Q2 2026 Earnings: EPS Miss of 16% Weighs on SharesEPS Consistency Score - careplusvn.com
This Certara Insider Increased Their Holding In The Last Year - Moomoo
Precision Trading with Certara Inc. (CERT) Risk Zones - Stock Traders Daily
Certara (CERT) Slashes Jobs While Doubling Down On Software Growth - Yahoo Finance
CERT Q2 2026 Earnings: EPS Misses Estimate by 16.05% as Shares Slip 3.02%Product Revenue Analysis - dars.gov.et
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - Eastern Progress
(CERT) Risk Channels and Responsive Allocation - Stock Traders Daily
Certara (NASDAQ: CERT) officer lines up $300K stock sale - Stock Titan
New RSU award sets 2027–2028 vesting for Certara (CERT) interim CFO - Stock Titan
Certara stock trades in the mid-$8 range as investors weigh growth and valuation - ad-hoc-news.de
Certara Inc. (CERT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Certara (CERT) Results Versus Estimates: EPS Misses Its Estimate in the Latest Session; After Results: The Stock Ends Down 3.44% in Latest TradingHigh Growth Earnings - vinanet.vn
Certara (CERT) Latest: Slides 3.44% to $8.43 in the Current Update; Range Check: the Near-Term Reference Band Stretches From $8.01 to $8.85 in the Latest SessionTrading Ideas - vinanet.vn
Tejara Capital Ltd Takes $8.47 Million Position in Certara, Inc. $CERT - MarketBeat
Faiz Mohammed Net Worth (2026) - GuruFocus
Certara (NASDAQ:CERT) Shares Up 5.9%Should You Buy? - MarketBeat
Why Did CERT Stock Fall Today? - Stocktwits
Guardian Small Cap Value Diversified VIP Fund's Certara Inc(CERT) Holding History - GuruFocus
The Technical Signals Behind (CERT) That Institutions Follow - Stock Traders Daily
Wasatch Advisors LP Sells 973,341 Shares of Certara, Inc. $CERT - MarketBeat
Royal Bank of Canada Trims Holdings in Certara, Inc. $CERT - MarketBeat
Ed Yardeni Raises S&P 500 Target For 2026 After ‘Gangbusters’ Earnings Season – Says He Wasn’t ‘Bullish Enough’ - Stocktwits
Loss-Making Certara, Inc. (NASDAQ:CERT) Expected To Breakeven In The Medium-Term - Moomoo
Renaissance Technologies LLC Has $2.02 Million Position in Certara, Inc. $CERT - MarketBeat
Certara Inc (CERT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certara Corrects EBITDA Disclosure in Earnings Presentation - The Globe and Mail
Is Certara (CERT) Still a Buy After +0.86% Rally? 2026-08-08Triple EMA - dars.gov.et
Form 8K Certara Inc For: 7 August By Investing.com - Investing.com Nigeria
Certara, Inc. (NASDAQ: CERT) corrects 2025 EBITDA for divested unit - Stock Titan
Certara, Inc. $CERT Shares Acquired by Quantinno Capital Management LP - MarketBeat
Certara, Inc. $CERT Shares Sold by Sei Investments Co. - MarketBeat
Bank of New York Mellon Corp Has $3.70 Million Stock Holdings in Certara, Inc. $CERT - MarketBeat
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Anhalt Rona | Chief Human Resources Officer |
Jun 01 '26 |
Option Exercise |
0.00 |
7,147 |
0 |
19,030 |
| Corcoran Daniel | SVP and General Counsel |
Jun 01 '26 |
Option Exercise |
0.00 |
22,830 |
0 |
39,939 |
| Collins Cynthia | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):